Galera Therapeutics, Inc. Common Stock

Go to Galera Therapeutics, Inc. Common Stock Website

$0.18

(%)
Live
Previous Close

$0.1751

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$9.5 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Galera Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. The Firm's lead product candidate, avasopasem ...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Galera's First Quarter 2024 Earnings Release

Related tickers: GRTX.

Read Full Article

MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that its Board of Directors (the “Board”) has unanimously resolved to adopt a limited duration stockholder rights agreement (the “Rights Agreement”) to protect stockholder interests.

Related tickers: GRTX.

Read Full Article
Trending Tickers
CYTO

XNAS

$0.00
0.00 (0.00%)
LASE

XNAS

$2.24
0.00 (0.00%)
MGAM

XNAS

$0.00
0.00 (0.00%)
SXTC

XNAS

$0.00
0.00 (0.00%)
MLGO

XNAS

$2.41
-0.05 (-2.03%)